|
INAB IN8bio Inc 1740279 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-5,090,000.00 |
| Balance Sheet |
|
Current Assets
|
$22,662,000.00 |
|
Assets
|
$26,265,000.00 |
|
Current Liabilities
|
$2,158,000.00 |
|
Liabilities
|
$3,484,000.00 |
|
Equity
|
$22,781,000.00 |
|
Shares Out
|
9847089.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-4,947,000.00 |
|
Investing Cash Flow
|
$-9,000.00 |
| Market Analysis |
Market Cap
|
$10,634,856.12 |
|
Price
|
$1.05 |
|
BVPS
|
2.31 |
|
PB
|
0.47 |
|
EPS
|
-0.26 |
|
FCF
|
$-4,947,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:44 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:44 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view INAB documents filed with the SEC.
INAB Filings
Clear
